Psychemedics (NASDAQ:PMD) Given Daily News Sentiment Score of 0.05

Press coverage about Psychemedics (NASDAQ:PMD) has been trending somewhat positive this week, according to Accern Sentiment Analysis. The research group identifies negative and positive media coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Psychemedics earned a coverage optimism score of 0.05 on Accern’s scale. Accern also assigned media stories about the company an impact score of 46.9662083972572 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

PMD traded down $0.32 during trading on Friday, reaching $20.12. 1,946 shares of the stock traded hands, compared to its average volume of 14,573. Psychemedics has a fifty-two week low of $15.99 and a fifty-two week high of $27.99. The stock has a market cap of $108.80, a price-to-earnings ratio of 22.01 and a beta of 0.73. The company has a current ratio of 3.28, a quick ratio of 3.28 and a debt-to-equity ratio of 0.13.

Psychemedics (NASDAQ:PMD) last announced its quarterly earnings results on Wednesday, March 7th. The company reported $0.22 earnings per share for the quarter. Psychemedics had a return on equity of 29.23% and a net margin of 15.42%. The company had revenue of $9.76 million during the quarter.

The business also recently declared a quarterly dividend, which was paid on Thursday, March 29th. Shareholders of record on Monday, March 19th were given a $0.15 dividend. The ex-dividend date of this dividend was Friday, March 16th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 2.98%.

ILLEGAL ACTIVITY WARNING: “Psychemedics (NASDAQ:PMD) Given Daily News Sentiment Score of 0.05” was first reported by BBNS and is owned by of BBNS. If you are accessing this report on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The legal version of this report can be viewed at https://baseballnewssource.com/2018/04/06/psychemedics-pmd-given-daily-news-sentiment-rating-of-0-05/2037607.html.

Psychemedics Company Profile

Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company's tests provide quantitative information that can indicate the approximate amount of drug ingested, as well as historical data, which can show a pattern of individual drug use over a longer period of time.

Insider Buying and Selling by Quarter for Psychemedics (NASDAQ:PMD)

Receive News & Ratings for Psychemedics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Psychemedics and related companies with MarketBeat.com's FREE daily email newsletter.

 




Latest News

Ji-Man Choi Receives Another Chance in Milwaukee
Ji-Man Choi Receives Another Chance in Milwaukee
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Marlins vs Dodgers sets a 10-year record in MGM sportsbooks
Strikeouts Once Again Plaguing Cubs
Strikeouts Once Again Plaguing Cubs
Atlanta Braves: A Mix of Young and Old
Atlanta Braves: A Mix of Young and Old
Major League Baseball is Back and Astros Favored to Repeat
Major League Baseball is Back and Astros Favored to Repeat
Jim Kaat: Baseball Would Be Helped by Shortening Game to Seven Innings
Jim Kaat: Baseball Would Be Helped by Shortening Game to Seven Innings


Leave a Reply

 
© 2006-2018 BBNS.